A detailed history of Pfw Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pfw Advisors LLC holds 3,018 shares of NVO stock, worth $325,974. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,018
Previous 3,091 2.36%
Holding current value
$325,974
Previous $397 Million 8.54%
% of portfolio
0.14%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$122.71 - $146.91 $8,957 - $10,724
-73 Reduced 2.36%
3,018 $431 Million
Q1 2024

Apr 11, 2024

BUY
$102.11 - $135.92 $1,531 - $2,038
15 Added 0.49%
3,091 $397 Million
Q4 2023

Jan 22, 2024

SELL
$87.78 - $105.45 $5,266 - $6,327
-60 Reduced 1.91%
3,076 $318 Million
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $142,593 - $312,878
1,568 Added 100.0%
3,136 $285 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $244,576 - $270,715
1,568 New
1,568 $285 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pfw Advisors LLC Portfolio

Follow Pfw Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfw Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfw Advisors LLC with notifications on news.